Cargando…
Guidelines for the Management of Cholestatic Liver Diseases (2021)
In 2015, the Chinese Society of Hepatology and the Chinese Society of Gastroenterology issued a consensus statement on the diagnosis and management of cholestatic liver diseases. More clinical data on this topic have appeared during recent years. The Autoimmune Liver Disease Group of the Chinese Soc...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
XIA & HE Publishing Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396310/ https://www.ncbi.nlm.nih.gov/pubmed/36062287 http://dx.doi.org/10.14218/JCTH.2022.00147 |
| _version_ | 1784771902678499328 |
|---|---|
| author | Lu, Lungen |
| author_facet | Lu, Lungen |
| author_sort | Lu, Lungen |
| collection | PubMed |
| description | In 2015, the Chinese Society of Hepatology and the Chinese Society of Gastroenterology issued a consensus statement on the diagnosis and management of cholestatic liver diseases. More clinical data on this topic have appeared during recent years. The Autoimmune Liver Disease Group of the Chinese Society of Hepatology organized an expert group to review recent evidence and provide an update to these previous guidelines. Herein, we provide 22 recommendations as a working reference for the management of cholestatic liver diseases by clinical practitioners. |
| format | Online Article Text |
| id | pubmed-9396310 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | XIA & HE Publishing Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93963102022-09-02 Guidelines for the Management of Cholestatic Liver Diseases (2021) Lu, Lungen J Clin Transl Hepatol Guideline In 2015, the Chinese Society of Hepatology and the Chinese Society of Gastroenterology issued a consensus statement on the diagnosis and management of cholestatic liver diseases. More clinical data on this topic have appeared during recent years. The Autoimmune Liver Disease Group of the Chinese Society of Hepatology organized an expert group to review recent evidence and provide an update to these previous guidelines. Herein, we provide 22 recommendations as a working reference for the management of cholestatic liver diseases by clinical practitioners. XIA & HE Publishing Inc. 2022-08-28 2022-04-29 /pmc/articles/PMC9396310/ /pubmed/36062287 http://dx.doi.org/10.14218/JCTH.2022.00147 Text en © 2022 Authors. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Guideline Lu, Lungen Guidelines for the Management of Cholestatic Liver Diseases (2021) |
| title | Guidelines for the Management of Cholestatic Liver Diseases (2021) |
| title_full | Guidelines for the Management of Cholestatic Liver Diseases (2021) |
| title_fullStr | Guidelines for the Management of Cholestatic Liver Diseases (2021) |
| title_full_unstemmed | Guidelines for the Management of Cholestatic Liver Diseases (2021) |
| title_short | Guidelines for the Management of Cholestatic Liver Diseases (2021) |
| title_sort | guidelines for the management of cholestatic liver diseases (2021) |
| topic | Guideline |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396310/ https://www.ncbi.nlm.nih.gov/pubmed/36062287 http://dx.doi.org/10.14218/JCTH.2022.00147 |
| work_keys_str_mv | AT lulungen guidelinesforthemanagementofcholestaticliverdiseases2021 AT guidelinesforthemanagementofcholestaticliverdiseases2021 |